Semax vs Selank: what the actual research says about these peptides

What did @elitehealthau actually say?

The creator laid out a clean two-column split: Selank handles "anti-anxiety and stress, emotional stability and mild cognitive function without the sedation feeling," while Semax is the performance side of the equation, covering "cognitive function, memory, focus." They also floated the idea that you can stack both together. No dosing advice, no disease claims, and a disclaimer that it's not medical advice. As TikTok peptide content goes, that's a relatively responsible starting point. But clean framing doesn't automatically mean accurate framing.

Both Semax and Selank are synthetic peptides developed in Russia, originally explored for neurological and anxiety-related conditions. They are not approved by the TGA in Australia or the FDA in the United States for any indication. That context is missing from the video entirely, and for a 3.2K-view audience, that omission matters.

Does the science back this up?

Partially, yes. The mechanistic split the creator describes is roughly consistent with the available research, though calling it "super simple" is doing a lot of heavy lifting. Selank's anxiolytic profile is the better-supported of the two claims here. Semax's cognitive performance framing is plausible but leaning on thinner human evidence.

Selank is a synthetic analogue of tuftsin. Animal and some early human studies suggest it modulates GABA-A receptors and affects serotonin and dopamine metabolism, which aligns mechanistically with an anxiolytic effect. Zozulya et al. (2008, CNS Drug Reviews) found Selank produced anxiolytic effects in clinical trials without sedation, which directly supports the creator's "without the sedation feeling" line. That's a fair call.

Semax is a synthetic analogue of ACTH(4-7). It's thought to increase BDNF (brain-derived neurotrophic factor) and modulate dopaminergic and serotonergic pathways. Agapova et al. (2007, Bulletin of Experimental Biology and Medicine) documented neuroprotective and cognitive-enhancing effects in animal models. Human trial data on healthy individuals chasing cognitive performance is far more limited. The creator presents Semax's cognitive effects as established fact. That's a stretch.

What did they get wrong (or right)?

The creator got the broad strokes right: Selank leans anxiolytic, Semax leans nootropic. These are reasonable characterisations based on mechanism and the available literature. Credit where it's due.

Where it gets sloppy is the framing of certainty. Saying Semax delivers "cognitive function, memory, focus" as if that's a confirmed outcome in healthy humans oversimplifies a literature that is mostly animal data and small Russian clinical trials. There's a real difference between "this peptide has shown neuroprotective effects in stroke patients" and "take this for focus," and the creator blurs that line.

The stacking suggestion, "if you wanna stack them together, you can," is the most casually delivered potentially consequential claim in the video. Stacking two centrally-acting peptides that both affect serotonin and dopamine pathways without any caveat about interaction risk or individual variability is irresponsible, even with a "not medical advice" disclaimer tacked on. The disclaimer doesn't neutralise the recommendation.

There is also zero mention of regulatory status, sourcing quality concerns, or the fact that neither peptide has TGA or FDA approval. For a platform that lists peptide therapy as a category, that omission is a problem.

What should you actually know?

Both peptides have genuinely interesting mechanistic profiles, and the research, while limited, is not nothing. But "interesting research" and "safe, effective, ready to self-administer" are not the same sentence.

First, the regulatory reality: in Australia, Semax and Selank are not approved therapeutic goods. Obtaining them typically means sourcing from compounding pharmacies or grey-market suppliers, and product quality is not guaranteed. Peptide purity and concentration vary significantly by source, which is a real safety variable that no TikTok video addresses.

Second, both peptides act on neurotransmitter systems. That's not trivial. Individual responses to GABAergic and dopaminergic modulation vary considerably. The "no sedation" claim for Selank is supported in clinical trials, but clinical trial populations are not the same as everyone watching this video.

Third, stacking centrally-acting peptides should not be treated as a casual lifestyle choice. If you're seriously considering either of these peptides, that conversation belongs with a prescribing clinician who can assess your individual situation, not a TikTok comment reply.

The bottom line

This video is more accurate than most peptide content you'll find on TikTok, but accuracy and completeness are different standards. The mechanistic framing is defensible, the certainty around cognitive performance outcomes is overstated, and the stacking suggestion needed more than a shrug. Know what the research actually shows before you treat this as a how-to guide.